date,title,source
Oct-17-18,Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference,PR Newswire
Oct-22-18,Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy,PR Newswire
Oct-24-18,Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek Cancer Diagnostic Test,PR Newswire
Oct-29-18,Anixa Biosciences to Present at SITC Annual Meeting,PR Newswire
Nov-12-18,Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference,PR Newswire
Nov-15-18,Anixa Biosciences To Present Cchek Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy,PR Newswire
Dec-03-18,Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference,PR Newswire
Dec-19-18,Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek Cancer Diagnostic Test,PR Newswire
Dec-26-18,"Should You Take Comfort From Insider Transactions At Anixa Biosciences, Inc. (NASDAQ:ANIX)?",Simply Wall St.
Jan-16-19,Anixa Biosciences to Hold Conference Call to Discuss Outlook for 2019,PR Newswire
Jan-24-19,Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance,PR Newswire
Jan-25-19,Anixa Biosciences Conference Call Recording Available on Company Website,PR Newswire
Feb-05-19,"What Are Analysts Saying About Anixa Biosciences, Inc.s (NASDAQ:ANIX) Earnings Trajectory?",Simply Wall St.
Feb-13-19,Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference,PR Newswire
Feb-21-19,"Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.",PR Newswire
Feb-25-19,Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek Prostate Cancer Confirmation Test,PR Newswire
Mar-04-19,Anixa Biosciences to Present Cchek Technology and Data at the Molecular Medicine Tri-Conference,PR Newswire
